Anxiety treatment serving Coral Springs — exposure-based CBT, in-house psychiatry.

For families in Coral Springs, Parkland, and Heron Bay, RECO Health is a 35-minute drive down the Sawgrass Expressway to specialist-level psychiatric care — measurement-based intake with GAD-7, PDSS, LSAS, and Y-BOCS, SSRI pharmacotherapy dosed at anxiety-appropriate ranges, and therapist-run Exposure and Response Prevention for OCD. Medication decisions are made in-house rather than deferred to a community prescriber, which lets dose adjustments happen inside the therapy window rather than three weeks later at a separate follow-up appointment.

Coral Springs sits roughly 25 miles inland from RECO Health’s Delray Beach campus — about 35 minutes down the Sawgrass Expressway and I-95 in ordinary traffic. For families in Eagle Trace, Hidden Hammocks, Parkland Isles, Cypress Run, and Heron Bay who have exhausted generalist counseling and primary-care prescribing, RECO offers specialist-level anxiety disorders treatment — measurement-based intake, disorder-specific exposure protocols, in-house psychiatry, and the established South Florida treatment community that has defined coastal recovery for decades.

Disorder-specific assessment before treatment starts

“Anxiety” is a presenting symptom, not a diagnosis, and the treatment plan that follows depends on which DSM-5-TR disorder the symptom belongs to. RECO’s intake team administers the GAD-7 for generalized anxiety severity, the Panic Disorder Severity Scale (PDSS) when unexpected panic attacks are the primary complaint, the Liebowitz Social Anxiety Scale (LSAS) when avoidance of social or performance situations dominates the clinical picture, and the Y-BOCS when compulsions or obsessional thinking are present. When trauma history is significant, the PCL-5 is added — PTSD is routinely mistaken for generalized anxiety in primary-care settings, and the treatment sequences do not overlap.

The distinction is not academic. Generalized anxiety disorder responds to worry-focused cognitive restructuring and worry-exposure work. OCD requires structured Exposure and Response Prevention with hierarchical stimulus lists. Social anxiety collapses if it is folded into a generic “anxiety group” without in-vivo behavioral experiments. Every treatment plan authored at RECO names the primary DSM-5-TR diagnosis, any co-occurring depression or substance use disorder, and the outcome measure that will be re-administered at two-week intervals to track response.

Co-occurring alcohol or benzodiazepine use disorder is common in this population and changes the treatment sequence — untreated substance dependence will keep anxiety scores artificially elevated regardless of psychiatric intervention, and stabilizing the substance-use component is often the precondition for the anxiety work to hold.

SSRI pharmacotherapy at anxiety-appropriate doses

Sertraline, escitalopram, paroxetine, and fluoxetine all carry FDA approvals for one or more anxiety disorders. Anxiety-effective dosing typically sits at the upper end of the range used for major depressive disorder — sertraline commonly reaches 150 to 200 mg, escitalopram 20 mg, paroxetine 40 to 60 mg — and initial titration is deliberately slow to avoid the activation, jitteriness, and paradoxical anxiety spike that can occur in the first two weeks. Clients who abandon SSRIs after five days of “feeling worse” often do so because the ramp was too fast, not because the medication was wrong.

Venlafaxine XR is a reasonable alternative when an SNRI is preferred, particularly for GAD with comorbid chronic pain. Buspirone is used as an augmentation strategy in GAD when SSRI response is partial. Hydroxyzine is available for as-needed use without the dependence and extinction-learning problems of benzodiazepines. Propranolol has a defined role in situational performance anxiety, typically 10 to 20 mg dosed 45 minutes before the feared event.

Medication decisions are made by RECO’s staff psychiatrists rather than referred out to a community prescriber, which allows dose adjustments to happen inside the therapy window rather than three weeks later at a follow-up appointment scheduled through a separate practice.

Exposure-based CBT is the therapy that works

Across every anxiety disorder, the evidence base points to exposure-based cognitive behavioral therapy rather than open-ended supportive talk therapy. For obsessive-compulsive disorder, that means Exposure and Response Prevention (ERP) — structured, therapist-guided exposure to feared stimuli paired with deliberate prevention of the compulsive response. For panic disorder, treatment centers on interoceptive exposure: deliberately reproducing feared bodily sensations (rapid heartbeat via stair climbs, dizziness via head rolls, chest tightness via straw breathing) so the client relearns that the sensations themselves are not dangerous.

For social anxiety disorder, the protocol is graded in-vivo exposure — a hierarchy of feared social situations worked through with therapist coaching and post-exposure cognitive processing. Acceptance and Commitment Therapy (ACT) is layered in when experiential avoidance is the maintaining mechanism, and DBT distress-tolerance skills are used adjunctively when emotion dysregulation interferes with sustained exposure.

At RECO, the individual exposure work is the treatment; the group programming, mindfulness-based skills training, and DBT modules exist to support that work rather than replace it. PHP clients typically attend individual CBT sessions two to three times per week with group programming filling the remainder of the day; IOP steps this down to weekly individual sessions with three group blocks per week.

Why we don’t lean on benzodiazepines

Alprazolam, lorazepam, and clonazepam relieve acute anxiety quickly, and that speed is the reason they remain widely prescribed in primary care. The clinical problem is twofold. First, benzodiazepines interfere with the extinction learning that makes exposure therapy work — a client who takes lorazepam before an ERP session is unlikely to encode the new learning that the feared outcome did not occur, and the exposure hierarchy stalls. Second, they carry meaningful dependence risk, and a significant share of RECO’s population meets criteria for a co-occurring substance use disorder in which any benzodiazepine prescription is contraindicated.

RECO’s default position is that benzodiazepines are avoided in any client with active or recent alcohol, opioid, or sedative-hypnotic use disorder, and used judiciously in others when a specific short-term indication exists. When situational bridging is genuinely needed — the two-week SSRI ramp, a defined procedural anxiety event, severe sleep disruption — hydroxyzine, gabapentin, or a short course of a low-dose beta-blocker cover most use cases without the dependence trajectory. Clients arriving on chronic benzodiazepine prescriptions are tapered on a structured schedule with medical oversight rather than stopped abruptly.

What the first visit looks like

Intake at RECO begins with a full psychiatric evaluation by a staff psychiatrist or psychiatric nurse practitioner, a substance-use history scored against the six ASAM Criteria dimensions to determine the appropriate initial level of care, and administration of the disorder-specific rating scales described above. Medical clearance labs — CBC, comprehensive metabolic panel, TSH, and urine toxicology — are drawn the same day.

Current psychiatric prescriptions are reviewed and continued or adjusted; nothing is stopped without a clinical reason and a taper plan when one is required. By the end of the first day, the client leaves with a written treatment plan naming the primary DSM-5-TR diagnosis, the outcome measure that will be tracked, the medication plan, the therapy modality, and the anticipated length of stay at each level of care. Family members are contacted with written consent and offered participation in the family program.

Insurance and admissions from Coral Springs

RECO Health is in-network with Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and BCBS across most behavioral health products. Benefits are verified before admission and out-of-pocket estimates — deductible, coinsurance, and expected length of stay at each level of care — are provided in writing rather than described in vague ranges. Single-case agreements and structured self-pay are available when a plan is out-of-network.

The drive from Coral Springs runs roughly 35 minutes via the Sawgrass Expressway to I-95 north in ordinary traffic. PHP and IOP clients typically arrange transportation through a family member during the first week and transition to independent driving as symptoms stabilize. Residential clients relocate to on-campus housing in Delray Beach for the duration of the stabilization phase, which removes the drive as a barrier during the highest-acuity portion of care.

Serving residents of: Eagle Trace, Hidden Hammocks, Parkland Isles, Cypress Run, Heron Bay.